2 Ways to Bet on the $830 Billion Telehealth Opportunity

Telehealth stocks like WELL Health Technologies (TSX:WELL) tap into an opportunity that could be worth $830 billion.

| More on:

Global healthcare is about to be disrupted. Over the past year, millions of people have received medical attention via video conferencing and ordered pharmaceutical drugs online. Telehealth gained mainstream adoption for the very first time. Now, this market is set to expand across the world and could be worth $830 billion by 2027. 

Here are two ways you can make an early bet on this immense market opportunity. 

Telehealth stock 1

WELL Health Technologies (TSX:WELL) is Canada’s market leader at the moment. This team got an early start and has managed to acquire enough clinics to become the largest private healthcare chain in the country. 

Over the past year, the team has acquired a telehealth platform, an online pharmacy and health tech startup in the United States. These strategic acquisitions have added multiple layers to WELL Health’s growth story. The company is currently worth $1.6 billion and expects an annual revenue run rate of $400 million in 2021. Put simply, this could be a multibagger tech stock over the next decade. That is if it lives up to expectations. 

Telehealth stock 2

CloudMD Software & Services (TSXV:DOC) has achieved tremendous success relatively quickly. Since its listing in 2018, its market value has increased tenfold to $374.1 million. Much like its larger rival, CloudMD achieved this pace of growth via aggressive acquisitions. 

The company offers software and service-based health technology solutions to healthcare facilities across Canada. There’s plenty of demand for quality healthcare through telemedicine and artificial intelligence. CloudMD currently supplies its solutions to 376 clinics and over 3,000 licensed Practitioners.

Impressive financial results have continued to affirm the company’s growth metrics. In the most recent quarter, the company reported a 187% year-over-year increase in revenue of $8.8 million. During the quarter, it closed 5 acquisitions and, in the process, added $13 million in annualized revenue. Additionally, the company has identified key acquisition targets that are expected to strengthen the core business.

Amid the robust revenue growth, CloudMD also boasts a strong cash position of $95 million on hand. That could shrink to $35 million when recent acquisitions are completed. But the cash position is still far greater than its debt load of $7 million.

Valuation

While the stock is not cheap, based on its price-to-sales multiple of 18, it is an ideal pick for investors eyeing exposure in the burgeoning telemedicine sector.

CloudMD has already proved it has the potential to be a stable, high margin, and fast-growing company. Robust revenue growth underscores its credibility in generating long-term shareholder value.

Bottom line

Healthcare technology took a big leap in 2020. With everyone confined to their homes, being able to connect with doctors via video and text messages probably saved lives. By 2027, this telehealth market could be worth over $830 billion. 

Canadian companies like WELL Health and CloudMD have first-mover advantages. They’ve been cementing their position in the market for years and are now poised for steady growth. Add these to your watch list if you’re trying to bet on the disruption of global healthcare. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has no position in any of the stocks mentioned.  Fool contributor Vishesh Raisinghani owns shares of WELL Health Technologies.

More on Tech Stocks

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Is OpenText Stock a Buy, Sell, or Hold for 2025?

OpenText stock has fallen in the last few years, but that could mean this top tech stock remains an undervalued…

Read more »

AI microchip
Tech Stocks

Celestica Stock: Buy, Sell, or Hold?

Celestica's stock price has rallied 950% in the last five years. Will the AI boom send it even higher in…

Read more »

data analyze research
Tech Stocks

2 Ridiculously Cheap Growth Stocks to Buy Hand Over Fist in 2024

Well Health Technologies is a cheap growth stock to buy for its record-breaking results, massive revenue growth, and profitability.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

4 Reasons to Buy Kinaxis Stock Like There’s No Tomorrow

Kinaxis stock has a strong past. But there is even more to look forward to from this top tech stock.

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

The Future of AI: Best Canadian Stocks to Buy Now

Here are two of the best AI-focused stocks in Canada that you can consider adding to your portfolio before it’s…

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Tech Stocks

2 TFSA Stocks to Buy Right Now With $7,000

Are you looking for growth stocks that can help you maximize the tax-free withdrawals of the TFSA? This article is…

Read more »

cloud computing
Tech Stocks

3 No-Brainer Tech Stocks to Buy Right Now for Less Than $1,000

Not all tech stocks are the risky investments that many think they are. Which is why we're focusing on the…

Read more »

An analyst uses a computer and dashboard for data business analysis and Data Management System with KPI and metrics connected to the database for technology finance, operations, sales, marketing, and artificial intelligence.
Tech Stocks

Where Will Open Text Stock Be in 5 Years?

OpenText stock is one of the few tech stocks that's been around for decades. But does it have what it…

Read more »